Article info
PDFHepatology
Original article
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis
- Correspondence to Sylvie Deuffic-Burban, ATIP-AVENIR Inserm U995, Parc Eurasanté, 152 rue du Docteur Yersin, 59120 Loos, France; sylvie.burban{at}neuf.fr
Citation
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis
Publication history
- Revised August 1, 2011
- Accepted August 14, 2011
- First published September 19, 2011.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.